Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.5250 (1.55%) ($8.3500 - $8.5250) on Tue. Jun. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.7% (three month average) | RSI | 51 | Latest Price | $8.5250(1.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(25%) XLRE(24%) ARKG(22%) SDY(21%) XAR(20%) | Factors Impacting BCRX price | BCRX will decline at least -1.35% in a week (0% probabilities). VIXM(-27%) VXX(-23%) VCIT(-16%) TLT(-15%) SHY(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.35% (StdDev 2.7%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.38(1.73%) | 10 Day Moving Average | $8.29(2.83%) | 20 Day Moving Average | $8.39(1.61%) | To recent high | -3.3% | To recent low | 15.6% | Market Cap | $1.504b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |